Alternative Medicine
The following information is specific for alternative and complementary medicine.
For additional evidence-based information on diseases, conditions, symptoms,
diagnosis, treatment and wellness issues, continue searching the
Healthwise Knowledgebase.
Also indexed as:
Adriamycin, Rubex
Doxorubicin is a chemotherapy drug used primarily to treat people with cancer.
An asterisk (*) next to an item in the summary
indicates that the interaction is supported only by weak, fragmentary,
and/or contradictory scientific evidence.
Pretreating people with the antioxidant coenzyme Q10 before administration of doxorubicin has reduced cardiac toxicity2 -an action also reported in animals.3 Some doctors recommend 100 mg per day.
The antioxidant supplement N-acetyl cysteine (NAC) has protected animals from the cardiotoxicity of doxorubicin,5 although human research has not been able to confirm these results.6 Most doctors do not yet suggest NAC for people taking doxorubicin.
The antioxidant vitamin C has protected against cardiotoxicity (damage to the heart) of doxorubicin in an animal study.8 In this trial, vitamin C significantly increased the life expectancy of mice and guinea pigs without interfering with anticancer action of the drug. Despite the lack of human data, some doctors recommend that patients taking doxorubicin supplement at least 1 gram of vitamin C per day.
Animal studies show that the antioxidant activity of vitamin E protects against doxorubicin-induced cardiotoxicity.9, 10 Test tube evidence suggests that vitamin E might also enhance the anticancer action of the drug.11 Human trials exploring the cardioprotective action of vitamin E in people taking doxorubicin remain inconclusive; however, some evidence suggests that vitamin E may allow for higher drug doses without increasing toxicity.12
Anecdotal reports indicate that very high (1,600 IU) amounts of vitamin E may reduce the amount of hair loss accompanying use of doxorubicin.13 However, while protection against hair loss was confirmed in a rabbit study, human research has not found this to be true.14
Alberts DS, Peng Y-M, Moon TE, Bressler R. Carnitine prevention of adriamycin toxicity in mice. Biomedicine 1978;29:265-8.
Judy WV, Hall JH, Dugan W, et al. Coenzyme Q10 reduction of Adriamycin® cardiotoxicity. In Biomedical and Clinical Aspects of Coenzyme Q, vol. 4, ed. K Folkers, Y Yamamura. Amsterdam: Elsevier/North Holland Biomedical Press, 1984, 231-41.
Ogura R, Toyama H, Shimada T, Murakami M. The role of ubiquinone (coenzyme Q10) in preventing Adriamycin®-induced mitochondrial disorders in rat heart. J Appl Biochem 1979;1:325.
Lissoni P, Barni S, Mandala M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer 1999;35:1688-92.
Doroshow JH, Locker GY, Ifrim I, et al. Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest 1981;68:1053-64.
Meyers C, Bonow R, Palmeri S, et al. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin Oncol 1983;10:53-5.
Pinto J, Raiczyk GB, Huang YP, Rivlin RS. New approaches to the possible prevention of side effects of chemotherapy by nutrition. Cancer 1986;58:1911-4.
Fujita K, Shinpo K, Yamada K, et al. Reduction of Adriamycin® toxicity by ascorbate in mice and guinea pigs. Cancer Res 1982;42:309-16.
Myers C, McQuire W, Young R. Adriamycin® amelioration of toxicity by alpha-tocopherol. Cancer Treat Rep 1976;60:961-2.
Sonneveld P. Effect of alpha-tocopherol on the cardiotoxicity of Adriamycin® in the rat. Cancer 1978;62:1033-6.
Ripoll EAP, Rama BN, Webber MM. Vitamin E enhances the chemotherapeutic effects of Adriamycin® on human prostatic carcinoma cells in vitro. J Urol 1986;136:529-31.
Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treatment Rev 1997;23:209-40 [review].
Wood LA. Possible prevention of Adriamycin®-induced allopecia by tocopherol. N Engl J Med 1985;312:1060 [letter].
Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treatment Rev 1997;23:209-40 [review].
The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires August 2007.
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information. For more information, click here.
